Citation: | LIANG Bo, YUAN Ding, WANG Jianye, ZHOU Shaolong, LIU Rongjun, WANG Xinjun. Global research trends of pyroptosis in tumor based on bibliometrics and visualization analysis[J]. Chinese Journal of General Practice, 2024, 22(10): 1781-1786. doi: 10.16766/j.cnki.issn.1674-4152.003733 |
[1] |
WU D Q, WEI C H, LI Y J, et al. Pyroptosis, a new breakthrough in cancer treatment[J]. Front Oncol, 2021, 11: 698811. DOI: 10.3389/fonc.2021.698811.
|
[2] |
FINK S L, COOKSON B T. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells[J]. Infect Immun, 2005, 73(4): 1907-1916. doi: 10.1128/IAI.73.4.1907-1916.2005
|
[3] |
VAN ECK N J, WALTMAN L. Software survey: VOSviewer, a computer program for bibliometric mapping[J]. Scientometrics, 2010, 84(2): 523-538. doi: 10.1007/s11192-009-0146-3
|
[4] |
CHEN C. Searching for intellectual turning points: progressive knowledge domain visualization[J]. Proc Natl Acad Sci U S A, 2004, 101 Suppl 1(Suppl 1): 5303-5310.
|
[5] |
CHEN C, DUBIN R, KIM M C. Emerging trends and new developments in regenerative medicine: a scientometric update (2000-2014)[J]. Expert Opin Biol Ther, 2014, 14(9): 1295-1317. doi: 10.1517/14712598.2014.920813
|
[6] |
HANAHAN D, WEINBERG R A. Hallmarks of cancer: the next generation[J]. Cell, 2011, 144(5): 646-674. doi: 10.1016/j.cell.2011.02.013
|
[7] |
TAN Y X, CHEN Q Z, LI X L, et al. Pyroptosis: a new paradigm of cell death for fighting against cancer[J]. J Exp Clin Cancer Res, 2021, 40(1): 153. DOI: 10.1186/s13046-021-01959-x.
|
[8] |
THI H T H, HONG S. Inflammasome as a therapeutic target for cancer prevention and treatment[J]. J Cancer Prev, 2017, 22(2): 62-73. doi: 10.15430/JCP.2017.22.2.62
|
[9] |
ZHOU C B, FANG J Y. The role of pyroptosis in gastrointestinal cancer and immune responses to intestinal microbial infection[J]. Biochim Biophys Acta Rev Cancer, 2019, 1872(1): 1-10. doi: 10.1016/j.bbcan.2019.05.001
|
[10] |
HSU S K, LI C Y, LIN I L, et al. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment[J]. Theranostics, 2021, 11(18): 8813-8835. doi: 10.7150/thno.62521
|
[11] |
WEI X, XIE F, ZHOU X, et al. Role of pyroptosis in inflammation and cancer[J]. Cell Mol Immunol, 2022, 19(9): 971-992. doi: 10.1038/s41423-022-00905-x
|
[12] |
NAGARAJAN K, SOUNDARAPANDIAN K, THORNE R F, et al. Activation of pyroptotic cell death pathways in cancer: an alternative therapeutic approach[J]. Transl Oncol, 2019, 12(7): 925-931. doi: 10.1016/j.tranon.2019.04.010
|
[13] |
LU C, GUO C, CHEN H, et al. A novel chimeric PD1-NKG2D-41BB receptor enhances antitumor activity of NK92 cells against human lung cancer H1299 cells by triggering pyroptosis[J]. Mol Immunol, 2020, 122: 200-206. doi: 10.1016/j.molimm.2020.04.016
|
[14] |
TIAN B, HUA Z, WANG Z, et al. RETRACTED ARTICLE: physcion 8-O-beta-glucopyranoside mediates the NLRP3-associated pyroptosis and cell metastasis in the human osteosarcoma cells via ER stress activation[J]. Naunyn Schmiedebergs Arch Pharmacol, 2021, 394(3): 555. DOI: 10.1007/s00210-020-01836-y.
|
[15] |
HAGE C, HOVES S, STRAUSS L, et al. Sorafenib induces pyroptosis in macrophages and triggers natural killer cell-mediated cytotoxicity against hepatocellular carcinoma[J]. Hepatology, 2019, 70(4): 1280-1297. doi: 10.1002/hep.30666
|
[16] |
REN N, JIANG T, WANG C, et al. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis[J]. Aging(Albany NY), 2020, 12(11): 11025-11041.
|
[17] |
WANG L, LI K, LIN X, et al. Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis[J]. Cancer Lett, 2019, 450: 22-31. doi: 10.1016/j.canlet.2019.02.014
|
[18] |
ZHANG Z, ZHANG Y, XIA S, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity[J]. Nature, 2020, 579(7799): 415-420. doi: 10.1038/s41586-020-2071-9
|
[19] |
FANG Y, TIAN S W, PAN Y T, et al. Pyroptosis: a new frontier in cancer[J]. Biomed Pharmacother, 2020, 121: 109595. DOI: 10.1016/j.biopha.2019.109595.
|
[20] |
XIA X J, WANG X, CHENG Z, et al. The role of pyroptosis in cancer: pro-cancer or pro-"host"?[J]. Cell Death Dis, 2019, 10(9): 650. DOI: 10.1038/s41419-019-1883-8.
|
[21] |
HOU J, ZHAO R, XIA W, et al. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis[J]. Nat Cell Biol, 2020, 22(10): 1264-1275. doi: 10.1038/s41556-020-0575-z
|
[22] |
MOOSSAVI M, PARSAMANESH N, BAHRAMI A, et al. Role of the NLRP3 inflammasome in cancer[J]. Mol Cancer, 2018, 17(1): 158. DOI: 10.1186/s12943-018-0900-3.
|